Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The results of several large trials have shown a small excess of
intracerebral haemorrhage among patients treated with aspirin. It is
not clear, however, whether individuals taking low dose aspirin for the
prophylaxis of vascular disease are at increased risk of intracerebral
haemorrhage. Thrift et al (p 759) therefore studied 331 hospital
patients and coroner's cases with intracerebral haemorrhage and
age and sex matched controls based in the community. They found no
increase in risk of intracerebral haemorrhage among aspirin users
overall or among those using low doses of the drug. Users of high doses
had a threefold increase in risk, but this finding requires confirmation.